Evidence map›Paper›PMID 39102883›Full record

ArticleJournal of the National Cancer Institute. Monographs2024

Machine learning and deep learning tools for the automated capture of cancer surveillance data.

Elizabeth Hsu, Heidi Hanson, Linda Coyle, Jennifer Stevens, Georgia Tourassi, Lynne Penberthy

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute. Monographs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The SEER Program's evolution: supporting clinically meaningful population-level research.Journal of the National Cancer Institute. Monographs · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth HsuSurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Heidi HansonAdvanced Computing for Health Sciences, Computing and Computational Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
Linda CoyleInformation Management Services Inc, Calverton, MD, USA.
Jennifer StevensInformation Management Services Inc, Calverton, MD, USA.
Georgia TourassiComputing and Computational Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, TN, USA.
Lynne PenberthySurveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Funding

Department of EnergyIMSJoint Design of Advanced Computing Solutions for CancerLos Alamos National Laboratory DE-AC5206NA25396NCI NIH HHSNIH HHSOak Ridge Leadership Computing FacilityOak Ridge National LaboratoryOak Ridge National Laboratory DE-AC05-00OR22725Office of Science DE-AC05-00OR22725
6 · The paper itself

Abstract

The National Cancer Institute and the Department of Energy strategic partnership applies advanced computing and predictive machine learning and deep learning models to automate the capture of information from unstructured clinical text for inclusion in cancer registries. Applications include extraction of key data elements from pathology reports, determination of whether a pathology or radiology report is related to cancer, extraction of relevant biomarker information, and identification of recurrence. With the growing complexity of cancer diagnosis and treatment, capturing essential information with purely manual methods is increasingly difficult. These new methods for applying advanced computational capabilities to automate data extraction represent an opportunity to close critical information gaps and create a nimble, flexible platform on which new information sources, such as genomics, can be added. This will ultimately provide a deeper understanding of the drivers of cancer and outcomes in the population and increase the timeliness of reporting. These advances will enable better understanding of how real-world patients are treated and the outcomes associated with those treatments in the context of our complex medical and social environment.

Indexed as

Deep LearningMachine LearningNeoplasmsHumansNational Cancer Institute (U.S.)RegistriesUnited States

Identifiers

PMID39102883
PMCPMC11300011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.